AI Verdict
REGN has stronger fundamentals based on our AI analysis.
REGN vs UNH Fundamental Comparison
| Metric | REGN | UNH |
|---|---|---|
| Revenue | $3.6B | $111.7B |
| Net Income | $727.2M | $6.3B |
| Net Margin | 20.2% | 5.6% |
| ROE | 2.3% | 6.0% |
| ROA | 1.8% | 2.0% |
| Current Ratio | 3.57x | 0.80x |
| Debt/Equity | 0.06x | 0.69x |
| EPS | $6.75 | $6.90 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
REGN vs UNH: Frequently Asked Questions
Is REGN or UNH a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), REGN has stronger fundamentals. REGN is rated BUY (80% confidence) while UNH is rated HOLD (77% confidence). This is not investment advice.
How does REGN compare to UNH fundamentally?
REGENERON PHARMACEUTICALS, INC. has ROE of 2.3% vs UNITEDHEALTH GROUP INC's 6.0%. Net margins are 20.2% vs 5.6% respectively.
Which stock pays higher dividends, REGN or UNH?
REGN has a dividend yield of N/A or no dividend while UNH has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in REGN or UNH for long term?
For long-term investing, consider that REGN has BUY rating with 80% confidence, while UNH has HOLD rating with 77% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about REGN vs UNH?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For REGN vs UNH, the AI consensus favors REGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.